Governance evidence
What agencies reported about the OMB M-25-21 minimum practices for high-impact AI. This is a disclosure analysis, not an audit, a compliance finding or an official assessment. An unanswered question is missing evidence, not evidence that a safeguard is absent.
Practice-by-practice evidence
Denominator: 10 records · use cases designated high-impact| Practice | In scope | In place | In progress | Not in place | N/A | Precluded or waived | Other | No answer | Answered | In place of applicable |
|---|---|---|---|---|---|---|---|---|---|---|
| Pre-deployment testing | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0% | 0% of 10 |
| AI impact assessment | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0% | 0% of 10 |
| Independent review | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0% | 0% of 10 |
| Ongoing monitoring | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0% | 0% of 10 |
| Operator training | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0% | 0% of 10 |
| Fail-safe | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0% | 0% of 10 |
| Appeal process | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0% | 0% of 10 |
| User and public consultation | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0% | 0% of 10 |
Answered = records with any answer ÷ records in scope. In place of applicable = reported in place ÷ (in scope minus not applicable, precluded and waived). Unanswered records stay in that denominator, so the rate is a lower bound on reported evidence, not an estimate of real practice.
| Testing | Impact assess. | Indep. review | Monitoring | Training | Fail-safe | Appeal | Consultation | n | |
|---|---|---|---|---|---|---|---|---|---|
| VA | – | – | – | – | – | – | – | – | 10 |
Hatched cells: the agency answered nothing for that practice, so there is no evidence either way. Compare agencies with care: each agency is one reporting unit, and portfolios differ in size and type.
Records requiring further investigation
10 records with at least one practice unanswered or in progressOpen in explorer| Use case | Stage | Test | AIA | Review | Monitor | Train | Fail-safe | Appeal | Consult |
|---|---|---|---|---|---|---|---|---|---|
| VA CART Adenoma Detection VA · VA-24-2008 | Deployed | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| Care Assessment Needs (CAN) Score VA · VA-24-5501 | Deployed | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| VA CART SYNTAX Risk Model VA · VA-24-5542 | Deployed | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| VA CART Mortality Model VA · VA-24-5583 | Deployed | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| VA CART Nephropathy Risk Model VA · VA-24-5624 | Deployed | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| VA CART Bleeding Risk Model VA · VA-24-5788 | Deployed | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| VASQIP Mortality Calculator VA · VA-25-4960 | Deployed | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| Frailty Risk Analysis VA · VA-25-5001 | Deployed | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| Lung Cancer Prediction Model VA · VA-24-3898 | Pilot | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| Screen for Esophageal Adenocarcinoma VA · VA-25-5375 | Pilot | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
Unanswered analytical questions
Generated from the data; for follow-up with agencies- VA designated 10 use cases high-impact but answered none of the minimum-practice questions for any of them. Were the practices assessed, and where is that recorded?
These are questions the inventory raises but cannot answer. They are not findings of non-compliance.